Key Metrics
Journal Specifications
- PublisherDOVE MEDICAL PRESS LTD
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2390
- Publication Time16
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2007
- Publisher URL
- Website URL
- Plagiarism
- Publication Time16
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 17% |
4-6 | 72% |
7-9 | 11% |
>9 | 0% |
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Biologics: Targets and Therapy been publishing?
The Biologics: Targets and Therapy has been publishing since 2007 till date.
How frequently is the Biologics: Targets and Therapy published?
Biologics: Targets and Therapy is published Continuous publication.
Who is the publisher of Biologics: Targets and Therapy?
The publisher of Biologics: Targets and Therapy is DOVE MEDICAL PRESS LTD.
How can I view the journal metrics of Biologics: Targets and Therapy on editage?
For the Biologics: Targets and Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Biologics: Targets and Therapy?
The eISSN number is 1177-5491 and pISSN number is 1177-5475 for Biologics: Targets and Therapy.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.